Hyperacute thrombosis of a vertebral artery stent with a single missed dose of a P2Y12 inhibitor and poor stent wall apposition: illustrative case.

Misa Fang, Manisha Koneru, Renato Oliveira, Joshua Santucci, Pratit Patel, Jane Khalife, Hamza A Shaikh, Daniel A Tonetti
{"title":"Hyperacute thrombosis of a vertebral artery stent with a single missed dose of a P2Y12 inhibitor and poor stent wall apposition: illustrative case.","authors":"Misa Fang, Manisha Koneru, Renato Oliveira, Joshua Santucci, Pratit Patel, Jane Khalife, Hamza A Shaikh, Daniel A Tonetti","doi":"10.3171/CASE24296","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Iatrogenic vertebral artery injury during surgery can cause pseudoaneurysm, hemorrhage, thrombosis, ischemia, or death. Strategies to prevent cerebrovascular embolic complications include surgical ligation, endovascular stenting, and/or antiplatelet therapy.</p><p><strong>Observations: </strong>A 73-year-old female with a known right vertebral artery occlusion underwent a C2-3 laminectomy, complicated by left vertebral artery injury and occlusion with subsequent posterior circulation ischemia. She underwent immediate angioplasty and stenting of the injured artery with undersized drug-eluting stents. Dual antiplatelet therapy of aspirin 81 mg daily and ticagrelor 90 mg twice daily was initiated. On two occasions, more than 6 months after stenting, holding a single ticagrelor dose led to in-stent thrombosis and embolic stroke within hours of the missed dose. Lifelong therapy with ticagrelor was favored over further procedural intervention.</p><p><strong>Lessons: </strong>It is recommended to prioritize optimal wall stent apposition with oversized stents in patients without collateral circulation. The risk of thromboembolism due to poorly apposed stents is very high, even in delayed (> 6 months) settings. Stent construct revision or bypass grafting may not be feasible or desirable options. For patients without wall apposition, endothelialization may not occur, necessitating lifelong P2Y12 inhibitor therapy to prevent recurrent thromboembolic events. https://thejns.org/doi/10.3171/CASE24296.</p>","PeriodicalId":94098,"journal":{"name":"Journal of neurosurgery. Case lessons","volume":"8 18","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11525754/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of neurosurgery. Case lessons","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3171/CASE24296","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Iatrogenic vertebral artery injury during surgery can cause pseudoaneurysm, hemorrhage, thrombosis, ischemia, or death. Strategies to prevent cerebrovascular embolic complications include surgical ligation, endovascular stenting, and/or antiplatelet therapy.

Observations: A 73-year-old female with a known right vertebral artery occlusion underwent a C2-3 laminectomy, complicated by left vertebral artery injury and occlusion with subsequent posterior circulation ischemia. She underwent immediate angioplasty and stenting of the injured artery with undersized drug-eluting stents. Dual antiplatelet therapy of aspirin 81 mg daily and ticagrelor 90 mg twice daily was initiated. On two occasions, more than 6 months after stenting, holding a single ticagrelor dose led to in-stent thrombosis and embolic stroke within hours of the missed dose. Lifelong therapy with ticagrelor was favored over further procedural intervention.

Lessons: It is recommended to prioritize optimal wall stent apposition with oversized stents in patients without collateral circulation. The risk of thromboembolism due to poorly apposed stents is very high, even in delayed (> 6 months) settings. Stent construct revision or bypass grafting may not be feasible or desirable options. For patients without wall apposition, endothelialization may not occur, necessitating lifelong P2Y12 inhibitor therapy to prevent recurrent thromboembolic events. https://thejns.org/doi/10.3171/CASE24296.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
单次漏服 P2Y12 抑制剂和支架壁贴合不良导致的椎动脉支架超急性血栓形成:示例病例。
背景:手术中先天性椎动脉损伤可导致假性动脉瘤、出血、血栓形成、缺血或死亡。预防脑血管栓塞并发症的策略包括手术结扎、血管内支架植入和/或抗血小板治疗:一名 73 岁的女性患者,已知右侧椎动脉闭塞,接受了 C2-3 椎板切除术,术后并发左侧椎动脉损伤和闭塞,随后出现后循环缺血。她立即接受了血管成形术,并用尺寸过小的药物洗脱支架对受伤的动脉进行了支架植入。她开始接受每天 81 毫克阿司匹林和每天两次每次 90 毫克替卡格雷的双重抗血小板治疗。在支架植入术后的 6 个多月里,有两次因未按时服用单一剂量的替卡格雷而导致支架内血栓形成,并在漏服后数小时内发生栓塞性中风。与进一步的手术干预相比,使用替卡格雷进行终身治疗更受青睐:启示:建议优先考虑在无侧支循环的患者中使用超大尺寸支架,以达到最佳的支架贴壁效果。由于支架贴壁不佳而导致血栓栓塞的风险非常高,即使在延迟(> 6 个月)的情况下也是如此。支架结构翻修或旁路移植可能不可行或不可取。对于没有贴壁的患者,可能不会发生内皮化,因此需要终生使用 P2Y12 抑制剂治疗,以防止再次发生血栓栓塞事件。https://thejns.org/doi/10.3171/CASE24296。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
0.40
自引率
0.00%
发文量
0
期刊最新文献
Convexity dural hemangioma: illustrative case. Detection of face motor activation in the precentral gyrus with functional thermography following inconclusive direct electrical stimulation mapping: illustrative case. Endovascular removal of a symptomatic intracranial foreign body via contact aspiration: illustrative case. Failed ulnar nerve surgery due to persistent unrecognized snapping triceps from cubitus varus due to a distal humeral malunion in an adult: illustrative case. Middle fossa approach for a petrous apex bony spur causing trigeminal neuralgia: illustrative case.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1